Concerns about the deleterious effects of stress on the mind and body have led to the beginnings of a stress vaccine, an injection that will reduce these effects.
Virtual Mentor issue editor Sophia Cedola, a medical student at Columbia University College of Physicians and Surgeons, interviewed Dr. Craig Blinderman about talking with patients who are terminally ill, asking him whether there are some key “do’s” and “don’ts” for having end-of-life conversations with patients and their families.
Patients who use drugs intravenously may be at high risk for relapse, but their situation is no more futile than that of persons with diabetes and coronary artery disease who smoke and frequent all-you-can-eat buffets.
Maureen Kelley, PhD discusses the dual-use dilemma in infectious disease research. The same scientific information or products intended for good can also fall into the wrong hands and be used to threaten a population in an act of bioterrorism.